Archives for August 30, 2016

US Enbrel biosimilar could be available as early as February 2017

Second for Sandoz, third for US as FDA approves Enbrel biosimilar

Sandoz says it will bring its version of Amgen’s Enbrel to patients as soon as possible after it became the third biosimilar to be approved in the US.

ISCT: Upfront manufacturing costs major obstacle to cell therapy innovation

The International Society for Cellular Therapy (ISCT) has called for a streamlined manufacturing regulatory pathway for cellular therapies to overcome the high upfront costs of manufacturing such products.